AbbVie Inc. Income Tax Expense 2011-2026 | ABBV
Beta
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is AbbVie Inc.'s current income tax expense?
AbbVie Inc. (ABBV) annual income tax expense for 2025 was $2.36B, a 514.74% increase from 2024. AbbVie Inc. income tax expense for the quarter ending March 31, 2026 was $342.0M.
What was AbbVie Inc.'s income tax expense in 2024?
AbbVie Inc. annual income tax expense for 2024 was $-570.0M, a 141.39% decline from 2023.
What was AbbVie Inc.'s income tax expense in 2023?
AbbVie Inc. annual income tax expense for 2023 was $1.38B, a 15.63% decline from 2022.
Income Tax Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-1.22B
→
FY2025
$2.36B
111213141516171819202122232425
5 years selected
Income Tax Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.36B | +514.7% | 10-K |
| FY2024 | $-570.0M | -141.4% | 10-K |
| FY2023 | $1.38B | -15.6% | 10-K |
| FY2022 | $1.63B | +13.3% | 10-K |
| FY2021 | $1.44B | +217.6% | 10-K |
| FY2020 | $-1.22B | -325.0% | 10-K |
| FY2019 | $544.0M | +211.0% | 10-K |
| FY2018 | $-490.0M | -120.3% | 10-K |
| FY2017 | $2.42B | +25.2% | 10-K |
| FY2016 | $1.93B | +28.6% | 10-K |
| FY2015 | $1.50B | +152.3% | 10-K |
| FY2014 | $595.0M | -50.6% | 10-K |
| FY2013 | $1.20B | +167.6% | 10-K |
| FY2012 | $450.0M | +91.5% | 10-K |
| FY2011 | $235.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →